TY - JOUR T1 - Serial interval of novel coronavirus (2019-nCoV) infections JF - medRxiv DO - 10.1101/2020.02.03.20019497 SP - 2020.02.03.20019497 AU - Hiroshi Nishiura AU - Natalie M. Linton AU - Andrei R. Akhmetzhanov Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/02/13/2020.02.03.20019497.abstract N2 - We estimated the serial interval of novel coronavirus (2019-nCoV) infections from 26 infector-infectee pairs. Accounting for right truncation, the median serial interval was estimated at 2.6 days and is shorter than estimates of the median incubation period, suggesting that a substantial proportion of secondary transmission occurs before illness onset.Competing Interest StatementThe authors have declared no competing interest.Funding StatementH.N. received funding support from Japan Agency for Medical Research and Development [grant number: JP18fk0108050] the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI in Japanese abbreviation) grant nos. 17H04701, 17H05808, 18H04895 and 19H01074, and the Japan Science and Technology Agency (JST) Core Research for Evolutional Science and Technology (CREST) program [grant number: JPMJCR1413]. NML receive graduate study scholarships from the Ministry of Education, Culture, Sports, Science and Technology, Japan.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data can be obtained from Supplementary Table. ER -